Establishment Labs Holdings Net Change in Intangible Assets 2017-2025 | ESTA
Establishment Labs Holdings net change in intangible assets from 2017 to 2025. Net change in intangible assets can be defined as the overall change from the sale and purchase of intangible assets including patents, rights and capitalized software.
| Establishment Labs Holdings Annual Net Change in Intangible Assets (Millions of US $) |
|
|---|---|
| 2024 | $-7 |
| 2023 | $-1 |
| 2022 | $-1 |
| 2021 | $-1 |
| 2020 | $-1 |
| 2019 | $-1 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.974B | $0.166B |
| Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.038B | 26.53 |
| CVS Health (CVS) | United States | $82.289B | 10.23 |
| Elevance Health (ELV) | United States | $65.480B | 8.81 |
| Cencora (COR) | United States | $56.344B | 18.77 |
| DiDi Global (DIDIY) | China | $25.603B | 27.20 |
| Labcorp Holdings (LH) | United States | $22.243B | 17.68 |
| Natera (NTRA) | United States | $21.553B | 0.00 |
| BioMerieux (BMXMF) | France | $17.652B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.635B | 0.00 |
| CochLear (CHEOY) | Australia | $13.465B | 0.00 |
| ICON (ICLR) | Ireland | $12.898B | 12.41 |
| Medpace Holdings (MEDP) | United States | $12.635B | 33.44 |
| Solventum (SOLV) | United States | $12.460B | 12.85 |
| Viatris (VTRS) | United States | $11.496B | 4.09 |
| Revvity (RVTY) | United States | $9.959B | 17.55 |
| Sonic Healthcare (SKHHY) | Australia | $8.980B | 0.00 |
| Avantor (AVTR) | United States | $8.249B | 12.10 |
| HealthEquity (HQY) | United States | $7.996B | 35.02 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.686B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.329B | 13.91 |
| Bausch + Lomb (BLCO) | Canada | $4.825B | 32.45 |
| Sotera Health (SHC) | United States | $3.994B | 22.32 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| BrightSpring Health Services (BTSG) | United States | $3.660B | 27.92 |
| GeneDx Holdings (WGS) | United States | $3.175B | 72.72 |
| Surgery Partners (SGRY) | United States | $2.915B | 36.68 |
| Alignment Healthcare (ALHC) | United States | $2.893B | 0.00 |
| Concentras Parent (CON) | United States | $2.753B | 17.46 |
| Organon (OGN) | United States | $2.342B | 2.55 |
| Premier (PINC) | United States | $1.922B | 14.59 |
| Progyny (PGNY) | United States | $1.870B | 39.54 |
| PACS (PACS) | United States | $1.731B | 0.00 |
| Ardent Health (ARDT) | United States | $1.723B | 6.65 |
| GoodRx Holdings (GDRX) | United States | $1.243B | 20.47 |
| Pediatrix Medical (MD) | United States | $1.230B | 8.21 |
| Teladoc Health (TDOC) | United States | $1.198B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Embecta (EMBC) | United States | $0.745B | 4.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.632B | 7.82 |
| CareDx (CDNA) | United States | $0.626B | 11.54 |
| Performant Healthcare (PHLT) | United States | $0.603B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.586B | 201.00 |
| Nutex Health (NUTX) | United States | $0.498B | 7.54 |
| Omada Health (OMDA) | $0.491B | 0.00 | |
| So-Young (SY) | China | $0.467B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.463B | 10.42 |
| SBC Medicals (SBC) | United States | $0.460B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.436B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.416B | 0.00 |
| Oncology Institute (TOI) | United States | $0.378B | 0.00 |
| Enhabit (EHAB) | United States | $0.369B | 24.27 |
| Agilon Health (AGL) | United States | $0.358B | 0.00 |
| LifeMD (LFMD) | United States | $0.319B | 0.00 |
| Beauty Health (SKIN) | United States | $0.278B | 0.00 |
| Shoulder Innovations (SI) | $0.185B | 0.00 | |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.141B | 0.00 |
| KindlyMD (NAKA) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.088B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |